Medical Oncologist
CION Cancer Clinics
Primary biliary cholangitis and cancer risk: what you should know | CION Cancer Clinics
Primary biliary cholangitis (PBC) raises the risk of liver cancer mainly once it has scarred the liver into cirrhosis. Most people who respond to treatment never reach that stage. This page explains where the risk comes from, who needs regular scans, how PBC differs from the bile duct disease that does carry a bile duct cancer risk, and what your own reports can tell you. At CION Cancer Clinics, our specialists help you understand your own risk and plan regular liver checks that fit it.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Does primary biliary cholangitis lead to cancer?
- Which people with PBC have a higher cancer risk?
- How is someone with PBC checked for liver cancer?
- Is PBC the same as primary sclerosing cholangitis?
- What do people with PBC often worry about that is not true?
- What this page cannot tell you
- Common questions about PBC and cancer
The short answer
Does primary biliary cholangitis lead to cancer?
Primary biliary cholangitis (PBC) raises the risk of liver cancer mainly once it has scarred the liver into cirrhosis. Most people with PBC who respond to treatment never reach that stage, and for them the cancer risk stays low.
What PBC is
PBC is a long-term condition in which the immune system slowly damages the tiny bile ducts inside the liver. Bile then backs up and irritates the liver around it. It used to be called primary biliary cirrhosis, but the name was changed because most people diagnosed today do not have cirrhosis. It is far more common in women, usually from middle age onwards. It is not caused by alcohol, diet or anything the person did, and it is not infectious.
How it is usually found
Many people have no symptoms at all. PBC is often picked up when a routine blood test shows a raised liver enzyme called ALP. Others notice tiredness, dry eyes or mouth, or itching that is worse at night.
Where the cancer risk comes from
If bile damage continues for years, scar tissue builds up. Widespread scarring is cirrhosis, and a cirrhotic liver can develop hepatocellular carcinoma (HCC), the most common primary liver cancer. Our page on how cirrhosis leads to cancer explains that pathway.
What moves the risk
Which people with PBC have a higher cancer risk?
A PBC diagnosis on its own says little about cancer. Four things tell your doctor much more.
Advanced scarring or cirrhosis
This is the main factor. Once cirrhosis is present, the liver is checked for cancer regularly for life, whatever the blood tests show.
A poor response to treatment
When the first medicine does not bring the liver enzymes down enough, bile damage carries on. These people are watched more closely and may be offered a second medicine.
Being a man with PBC
PBC is uncommon in men, but men who have it appear to develop liver cancer more often than women with PBC. Doctors keep this in mind when planning checks.
Other strain on the same liver
Alcohol, fatty liver and hepatitis B or C each add damage of their own.
Mention these to your doctor
- Any regular drinking
- Diabetes or weight gain
- Past hepatitis test results
Not sure whether this applies to you?
Ask an oncologistKeeping watch
How is someone with PBC checked for liver cancer?
Measure the scarring
Blood tests, an ultrasound and a liver stiffness scan called elastography (FibroScan) show how much scarring there is. CION arranges these through partner hepatologists and diagnostic centres.
Check the response to treatment
The main medicine for PBC is ursodeoxycholic acid (UDCA). Your hepatologist repeats liver blood tests to see whether it is working well enough. A good response protects the liver over the long term.
Regular ultrasound if there is cirrhosis
People with PBC and cirrhosis are usually offered an ultrasound every six months, often with an AFP blood test. Our page on the six-monthly ultrasound explains why that interval is used.
Follow up anything new
A new spot on the ultrasound usually leads to a CT or MRI with contrast. Many spots in a scarred liver turn out to be harmless, but each one needs that next scan.
Plan treatment if cancer is found
The CION tumour board plans around the tumour and around how well the liver is still working.
Side by side
Is PBC the same as primary sclerosing cholangitis?
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
Damages the tiny bile ducts inside the liver
Scars the larger bile ducts, inside and outside the liver
Mostly affects women, from middle age
More common in men, often linked with bowel inflammation
Cancer risk is mainly HCC, once cirrhosis forms
Carries a clear risk of bile duct cancer (cholangiocarcinoma)
Usually responds to UDCA
No medicine has been shown to slow it reliably
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do people with PBC often worry about that is not true?
"The old name had cirrhosis in it, so I must have cirrhosis."
The name was changed precisely because most people diagnosed today have little or no scarring. Your own scans and stiffness test tell you which stage you are at.
"My liver tests improved, so I can stop the tablets."
Improved tests are usually the medicine doing its job. PBC is lifelong, and the treatment normally continues. Talk to your hepatologist before changing anything.
"Itching means the cancer has started."
Itching is one of the commonest PBC symptoms and comes from bile backing up. It does not signal cancer. It can be treated, so do mention it rather than putting up with it.
"A liver detox will clear the blocked bile."
No tonic or detox product clears PBC, and some herbal products injure the liver, especially a scarred one. Tell your doctor what you take, and expect no judgement for it.
Being straight with you
What this page cannot tell you
It cannot tell you how much scarring your liver has, whether your treatment response is good enough, or what your own cancer risk is. Those answers come from your blood tests, your stiffness scan and a hepatologist who has followed you over time.
Who this does not apply to
This page is not about bile duct cancer from other causes, such as stones or liver fluke infection. Those are covered on bile duct stones, cholangitis and cancer risk. It is also not about a liver spot that has spread from another organ. If that is your situation, read primary versus secondary liver cancer.
Where the evidence is thin
PBC is uncommon, and most research comes from Europe, North America and East Asia. There is very little Indian data. Newer second-line medicines are not equally available everywhere, and access in India can change, so ask your hepatologist what is available to you now.
If you have PBC with cirrhosis and are not having regular ultrasound scans, raise it at your next appointment.Questions we are asked
Common questions about PBC and cancer
Is primary biliary cholangitis a cancer?
No. PBC is an autoimmune disease of the small bile ducts. It is not cancer and does not turn into cancer directly. The risk of liver cancer rises mainly if long-term damage scars the liver into cirrhosis, which good treatment often prevents or delays for many years.
Does PBC cause bile duct cancer?
Despite affecting the bile ducts, PBC is not strongly linked with bile duct cancer. Its main cancer link is with HCC in a cirrhotic liver. The bile duct condition with a clear cholangiocarcinoma risk is primary sclerosing cholangitis, a different disease that is sometimes confused with PBC.
I have PBC without cirrhosis. Do I need cancer scans?
Usually not on a fixed cancer schedule. Your hepatologist will still repeat blood tests and check scarring from time to time. If a stiffness scan or ultrasound later shows advanced scarring, regular cancer surveillance would then begin. Ask at each review what your scarring stage is.
Can PBC be controlled?
For most people, yes. UDCA slows the disease well in many patients, and some who do not respond fully can be offered a second medicine. PBC is lifelong, so treatment usually continues indefinitely. Staying on it is the most effective way to protect the liver.
Will my daughter get PBC?
PBC runs in some families, and close female relatives have a somewhat higher chance than the general population. Most still never develop it. A simple liver blood test can be done if she has symptoms or wants reassurance. There is no reason for guilt; you did not cause this.
What helps with the itching?
Several medicines can ease PBC itching, and your hepatologist will choose based on your other treatment. Cool showers, moisturiser and loose cotton clothing help a little. Severe itching that stops you sleeping is a real problem worth raising, not something to quietly tolerate.
Does PBC affect anything besides the liver?
It often comes with dry eyes and mouth, thyroid problems and thinning bones. Your doctor may suggest a bone density scan and thyroid tests. These are part of good PBC care, separate from the question of cancer risk.
Who do I contact if a scan shows something?
Keep your hepatologist involved, since they know your PBC best. If a scan has found a spot or you want an oncologist's opinion, call the CION helpline. A CION oncologist can review your reports and arrange further scans through partner centres.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- NHS — Primary biliary cholangitis
- NIDDK — Primary Sclerosing Cholangitis - NIDDK
- American Cancer Society — Liver Cancer Risk Factors
- NIDDK — Cirrhosis - NIDDK
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Autoimmune hepatitis and cancer riskThe other autoimmune liver disease, and how its risk comparesWhat is my cancer risk with cirrhosis?The factor that matters most once scarring has formedThe six-monthly ultrasoundWhat regular liver surveillance involvesWhat causes intrahepatic cholangiocarcinomaIf your worry is bile duct cancer specifically
Talk to us
Living with PBC and worried about a scan result?
Send us your scans and blood reports and a CION oncologist will explain what they show and what the sensible next step is. One helpline serves every CION centre.